Table 6

Groups of weight loss and liver function parameters in patients with NGLCD
Weight gain 1-5% weight loss 5-10% weight loss Weight loss >10% p
Mean SD Mean SD Mean SD Mean SD
PA (min/week) Baseline 17.0 3.9 27.5 16.2 34.4 23.6 28.7 20.8 0.310
12-months 46.0 21.0 74.1 39.7 106.2 40.7 114.5 26.6 0.002
Weight (kg) Baseline 85.4 15.0 85.8 15.1 82.9 11.1 77.9 6.7 0.592
12-months 86.5 14.5 83.6 14.7 76.4 10.7 67.7 6.2 0.024
BMI (kg/m2) Baseline 28.7 3.8 29.6 3.1 30.4 4.6 27.2 0.8 0.295
12-months 29.1 3.6 28.9 3.0 28.0 4.5 23.6 0.6 0.011
AST (IU/l) Baseline 44.8 25.0 51.8 31.7 61.8 45.2 32.3 16.9 0.336
12-months 35.1 17.9 46.3 22.4 51.9 36.4 35.7 12.5 0.460
ALT (IU/l) Baseline 41.5 24.9 68.7 42.0 61.3 44.9 35.2 26.7 0.213
12-months 31.5 14.5 53.6 28.0 54.9 31.4 34.2 19.2 0.168
Albumin (g/dl) Baseline 4.4 0.5 4.3 0.3 4.2 0.4 4.4 0.3 0.430
12-months 4.3 0.3 4.4 0.4 4.4 0.4 4.5 0.2 0.744
Bi (g/dl) Baseline 0.6 0.3 0.7 0.2 0.6 0.2 0.6 0.1 0.566
12-months 0.6 0.3 0.6 0.2 0.6 0.2 0.6 0.1 0.653
GGT (IU/l) Baseline 36.4 23.7 58.4 31.1 59.4 47.8 39.3 26.1 0.403
12-months 30.8 19.2 51.9 34.2 46.9 29.3 24.3 8.0 0.152
AST/ALT Baseline 1.2 0.4 0.8 0.3 1.1 0.5 1.1 0.5 0.050
12-months 1.1 0.2 0.9 0.2 1.0 0.3 1.2 0.5 0.075
FI Baseline 5.5 0.7 5.8 1.2 5.6 1.2 4.6 0.5 0.160
12-months 5.3 0.5 5.6 1.1 5.4 1.3 4.3 0.5 0.086
APRI Baseline 0.6 0.4 0.7 0.5 0.9 0.8 0.4 0.2 0.419
12-months 0.5 0.3 0.6 0.4 0.7 0.6 0.4 0.2 0.596

NGLCD normoglucidic low-calorie diet, PA physical activity, BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, Bi bilirubin, GGT gamma-glutamyl transpeptidase, AST/ALT aspartate aminotransferase/alanine aminotransferase ratio, FI Forns fibrosis index, APRI AST to platelet ratio index.

Rusu et al.

Rusu et al. Nutrition Journal 2013 12:119   doi:10.1186/1475-2891-12-119

Open Data